Zofran litigation
Claims alleged that Zofran, widely prescribed off-label for morning sickness, was linked to congenital heart defects and cleft palate.
Free case review
What the claims alleged
Zofran was never approved for use in pregnancy, yet it became one of the most prescribed morning sickness treatments in the country. The litigation alleged the manufacturer promoted that use while epidemiological signals connected first-trimester exposure to heart and orofacial defects.
Injuries named in the litigation
- Congenital heart defects
- Cleft lip and cleft palate
- Kidney malformations
Who may qualify
If you took Zofran in early pregnancy and your child was born with a heart defect or cleft palate, you may have a claim. The review is free and confidential, and we will give you an honest answer either way. You pay attorney's fees only if we recover for you.
Call (888) 391‑1315 or use the form for a free, confidential review. You pay attorney's fees only if we recover for you.